HCA Healthcare, Inc. (NYSE:HCA) Holdings Reduced by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,392 shares of the company’s stock after selling 2,175 shares during the period. Commonwealth Equity Services LLC’s holdings in HCA Healthcare were worth $5,820,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Evergreen Private Wealth LLC grew its position in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after acquiring an additional 36 shares in the last quarter. Mediolanum International Funds Ltd boosted its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Hartford Funds Management Co LLC boosted its holdings in shares of HCA Healthcare by 1.6% in the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after acquiring an additional 39 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its holdings in shares of HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after acquiring an additional 40 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 1.3 %

HCA stock opened at $329.25 on Friday. The company has a 50 day moving average of $321.50 and a two-hundred day moving average of $343.43. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market cap of $81.06 billion, a price-to-earnings ratio of 14.99, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Analyst Ratings Changes

Several research firms recently commented on HCA. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Bank of America cut their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Morgan Stanley reduced their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada reduced their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.